Doctors Changed One Thing and Weight Gain Stopped
A new weight management system developed by an endocrinologist transformed how primary care clinics address obesity. In one…
Keeping rebound weight off after stopping GLP-1 drugs
For many, GLP-1 (glucagon-like peptide-1) drugs like tirzepatide and semaglutide offered an ideal solution to diabetes and weight…
People are battling ‘ghost fat’ after losing weight on GLP-1s
Sometimes, seeing isn’t believing. Across the country, Americans are losing weight faster than ever thanks to blockbuster obesity…
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
Research Highlights:
Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer…
Data raises questions about long-term effects of GLP-1 therapies
Eos SENOLYTIX says new preclinical findings highlight body composition and healthy aging as the next frontier in obesity medicine. A…
How a diabetes drug became a weight-loss hack, and why doctors are concerned
Dr Kimberly Chew, principal clinical psychologist at AO Psychology, which offers counselling and psychotherapy services, said that the…
GLP-1 treatments may reduce knee replacement surgery rates
GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with…
Healthy habits boost Long-Term health for cancer survivors
Maintaining a healthy weight and staying physically active may do more to protect childhood cancer survivors from diabetes,…
Pediatric experts reveal the 10 research areas set to shape child health
From gene therapy and AI to vaccines, nutrition, and cancer care, pediatric research leaders outline where the next…
Can Wegovy move the needle on NZ’s obesity crisis, or simply treat its symptoms? – Opinion
This has strengthened arguments that public funding could improve equity while reducing long-term healthcare costs. All the while,…
Exercise less, burn more fat: Scientists unveil a simple method for weekly weight loss
By یورونیوز فارسی Published on 30/05/2026 – 7:00 GMT+2 According to a new study, doing interval training just once…
Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more…